Sansure Biotech Inc - Asset Resilience Ratio

Latest as of March 2026: 1.58%

Sansure Biotech Inc (688289) has an Asset Resilience Ratio of 1.58% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688289 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

CN¥151.64 Million

≈ $22.19 Million USD Cash + Short-term Investments

Total Assets

CN¥9.61 Billion

≈ $1.41 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Sansure Biotech Inc's Asset Resilience Ratio has changed over time. See Sansure Biotech Inc balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Sansure Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sansure Biotech Inc (688289) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥151.64 Million	1.58%
Total Liquid Assets	CN¥151.64 Million	1.58%

Asset Resilience Insights

Limited Liquidity: Sansure Biotech Inc maintains only 1.58% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sansure Biotech Inc Industry Peers by Asset Resilience Ratio

Compare Sansure Biotech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tecan Group AG SW:TECN	Medical Instruments & Supplies	20.48%
Nanosonics Ltd AU:NAN	Medical Instruments & Supplies	46.84%
SWS Hemodialysis Care Co. Ltd. A SHG:688410	Medical Instruments & Supplies	38.45%
Formosa Optical Technology Co Ltd TWO:5312	Medical Instruments & Supplies	46.32%
ZEN Graphene Solutions Ltd V:ZEN	Medical Instruments & Supplies	4.79%
GETS Global Bhd KLSE:5079	Medical Instruments & Supplies	0.03%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%
SDI Ltd AU:SDI	Medical Instruments & Supplies	3.36%

Annual Asset Resilience Ratio for Sansure Biotech Inc (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Sansure Biotech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.65%	CN¥157.10 Million ≈ $22.99 Million	CN¥9.53 Billion ≈ $1.39 Billion	+0.03pp
2024-12-31	1.62%	CN¥139.67 Million ≈ $20.44 Million	CN¥8.60 Billion ≈ $1.26 Billion	-4.86pp
2023-12-31	6.49%	CN¥548.28 Million ≈ $80.23 Million	CN¥8.45 Billion ≈ $1.24 Billion	-20.23pp
2022-12-31	26.72%	CN¥2.45 Billion ≈ $358.69 Million	CN¥9.17 Billion ≈ $1.34 Billion	-2.14pp
2021-12-31	28.86%	CN¥2.05 Billion ≈ $299.46 Million	CN¥7.09 Billion ≈ $1.04 Billion	-0.49pp
2020-12-31	29.36%	CN¥1.60 Billion ≈ $234.31 Million	CN¥5.45 Billion ≈ $798.15 Million	+19.03pp
2019-12-31	10.32%	CN¥66.33 Million ≈ $9.71 Million	CN¥642.47 Million ≈ $94.01 Million	--

pp = percentage points

About Sansure Biotech Inc

SHG:688289 China Medical Instruments & Supplies

Market Cap

$1.19 Billion

CN¥8.15 Billion CNY

Market Cap Rank

#8299 Global

#2019 in China

Share Price

CN¥14.07

Change (1 day)

-0.85%

52-Week Range

CN¥14.07 - CN¥22.94

All Time High

CN¥81.40